Patient Story
Developed under the direction and sponsorship of Sanofi US and Regeneron Pharmaceuticals, Inc. Important Safety Information Full Prescribing Information INDICATION DUPIXENT® (dupilumab) is indicated for the treatment of adult and pediatric patients aged 6 months and older with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies […]
ADA® Standards of Care Information
TK Prescribing Information and Medication Guide JARDIANCE is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure. JARDIANCE is indicated to reduce […]
Results from the T2D Monotherapy Trial
TK Prescribing Information and Medication Guide JARDIANCE is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure. JARDIANCE is indicated to reduce […]
Peercast 1
Sponsored by Grifols As healthcare providers, we know the importance of early and accurate diagnosis for our patients. Alpha1-antitrypsin deficiency (AAT deficiency) can be challenging to identify due to its similar presentation to chronic obstructive pulmonary disease (COPD) and asthma. Evaluating symptoms alone is not sufficient for diagnosis; genetic testing is essential. I encourage you […]
Results from the
Empa-Kidney Trial
TK Prescribing Information and Medication Guide JARDIANCE is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure. JARDIANCE is indicated to reduce […]
Safety Profile
Dosing Information
TK Prescribing Information and Medication Guide JARDIANCE is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure. JARDIANCE is indicated to reduce […]
Information about JARDIANCE
TK Prescribing Information and Medication Guide JARDIANCE is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure. JARDIANCE is indicated to reduce […]
Multiple Myeloma: Fast Facts
Multiple Myeloma: Fast Facts Multiple myeloma is a type of blood cancer that affects plasma cells, which are a type of white blood cell responsible for producing antibodies.1 The average lifetime risk of getting multiple myeloma is approximately 1 in 103 for men and about 1 in 131 for women in the United States.2 1.8% of All […]
Multiple Myeloma: Signs and Symptoms
Multiple Myeloma: Signs and Symptoms Patients may experience no symptoms in the early stages of multiple myeloma.1 When patients do experience symptoms, they commonly include1: While there is no known way to prevent a diagnosis of multiple myeloma, risk factors of the disease include older age, male gender, African American ethnicity, a family history of multiple myeloma, […]